Jlang, Holy smokes, I guess we disagree even more this

New Post Public Reply Private Reply Replies (1) Message Board
CTMedic JLang #102252
513
Jlang,

Holy smokes, I guess we disagree even more this afternoon. However, I'll try to address your claims that I have a "drastically less than complete grasp" of the topic under discussion.

Quote:
Mutation rate isn't moot, it's baseline.. this is about Variants of Concern vs previous variants they're outclassing. For the nth time. They all have roughly the same mutation rate regardless of host.. it's non-relevant with respect to this comparison, not irrelevant in general. You don't comprehend this.


I agree mutation rate isn't moot, though I don't believe that "baseline" is anywhere in the world a synonym for moot. Mutation is the basis from which evolution of variants has the opportunity to occur. Higher mutation rate, equals greater opportunity for change.

I am glad that you finally appreciate that mutations occur roughly at the same rate, irrespective of host immune competence. Until the virus clears (a few weeks in healthy patients, many months in immune compromised patients) viral replication continues with resultant mutations.

Previously you argued:

Quote:
You're approaching it from a mathematical standpoint.. it's not about mutation opportunities, it's about selective pressures. They're uniquely geared towards improving binding affinity and virulence in the immunocompromised.. of which those with HIV are a significant part.


For review, selective pressures are unable to drive development of variants without mutations, some of which may have increased fitness.

Quote:
Again, immune evasion is not the only or I'd argue even the primary selective force for a novel virus.. binding affinity and transmission are of higher relative importance. The strength of the host immune system does matter: in that weaker ones allow the pathogen more time to become familiar and increase binding affinity to the pathogens receptors of choice. This is elementary. You don't comprehend this.


All three characteristics, immune evasion, binding affinity / viral entry and transmission can drive viral fitness.

Immune evasion undoubtedly matters, as improved immune evasion allows covid to persist among a population. This is the crux of the concern that neutralizing antibodies and vaccines will fail to protect.

Weakened host immune response allows continued viral replication, it is unequivocally NOT a selective pressure driving improved binding affinity. The compromised host allows relatively unimpeded viral reproduction, in fact permitting reproduction of "less fit" visions which would be eradicated by a healthy immune system, the exact opposite of what you claim.

I'll try to make this even more simple. Imagine two herd of goats, one living in a valley with enough food and water, but hungry wolves (representing a competent immune system). The goats have an opportunity to reproduce and thrive, but are constantly under attack by wolves. Variation through procreation occurs in these goats, but the presence of the wolves selects for the goats that are the most fleet of foot, wary, and able to reproduce with precocious young (able to run and flee at birth). The eventual result is a population of fast, evasive, and precocious goats.

The second valley, our incompetent immune system, allows the goats to reproduce with just a few lazy third rate goats. Variation among the goats will still occur during reproduction, but without a significant threat from the wolves, the goats remain unchanged without increased wariness, evasion, precious young and accelerated reproduction.The goats, if isolated and separated from predatory threats remain a mixed bag, perhaps even become slower and more slothful (evolution island hypothesis). Only the goats who leave there valley and are tested by wolves and other existential threats will become a more fit variant.

Again compromised host - valley without wolves = mutation opportunity

Valley full of threats = selective pressure

Quote:
A strong, functional host doesn't allow the pathogen the luxury of time to increase binding affinity, as evidenced by the multitude of papers describing weeks-months long, active covid infections in the immunocompromised, with several advantage conferring mutations, with sequential viral samples/references exquisitely building the roadmap of these accumulated mutations... And literally zero of the same detailing a similar process in hosts that have a disease course that lasts for days, max. I've posted several, read them on repeat until it sinks in.
Quote:


I concur that prolonged infection in immunocompromised hosts presents an increased opportunity for mutation and variant emergence. However, immune competent patients still generate very high viral loads, as previously discussed. With high mutation rate, each of the virions, presents a new opportunity for a variant to emerge.

Each virion exists as an independent infective agent, not needing "luxury of time to increase binding affinity." It is either sufficiently fit to bind to the requisite cell surface protein (ACE2, or if it's lucky, a new protein with which it is now able to fuse), enter the cell and reproduce or it is not. Every organism that does not reproduce is an evolutionary dead end.

Please recall RNA virus can explode from a single copy to 100K in 10 hours, with viral loads of 10^12. Again, I concur that immune suppressed patients maintaining high viral titers are an increased opportunity for variant emergence, but so is ongoing infection amongst many millions worldwide.

https://www.researchgate.net/publication/2033...NA_viruses

Quote:
And literally zero of the same detailing a similar process in hosts that have a disease course that lasts for days, max.


Jlang, are your truly arguing that viral mutation only occurs among the immunocompromised?

No viral, bacterial or fungal evolution occurred prior to HIV, chemotherapy and steroids?

Laughable.

Quote:
The immunocompromised allow for mutations in the most crucial of those factors.. for a Novel Virus.. binding affinity to a new species receptor.


I concur, again, that immune compromised patients allow ongoing viral replication and mutation.

Mutation is simply the results of erroneous nucleotide substitution during transcription. Most errors are deleterious, some are neutral and a chance few are advantageous. The advantageous mutations will not reveal themselves, and potentially result in variants, until they emerge and "try their hand" infecting the immune competent, or even more challenging, the immune competent and vaccinated or previously infected.

There is no selective pressure exerted by the weak favoring the strong. Covid virions in immunocompromised patients have already demonstrated the ability to infect via ACE2 or the patient would not be infected. The hurdles for further infection may actually decrease over time in the infected host through syncytia formation.

Quote:
The non-compromised hosts don't have "healthier locks".. they have roughly the same ACE2 receptors as the immunocompromised. The virus has less time trying to pick at ACE2 in a healthy host. Less mutations.. even you can't argue this. And what you don't understand is, this process is iterative and *greater at driving the increase in binding affinity of the viral spike protein and ACE2 in compromised hosts*. The exact opposite of what you're suggesting.


The selective pressures are in fact the opposite of what YOU suggest. A more fit variant is one that is is successful even when "The virus has less time trying to pick at ACE2 in a healthy host."

Ever watched sport competitions? I'm impressed by the contestants on American Ninja Warrior.

Now, if we send a thousand people out of the course and gave them weeks to practice, eventually one will finish. However, who is the better athlete (successful varian), the one who FINALLY prevails or the one who races out of the gate and flashes the course in record time, the first time.

That is your new and dangerous variant.

Don't give up. You'll get it eventually.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Spotlight on AI-Powered Smart Homes for 2027

Updated Category News Views 6

Gearing Up for the Connected Home Revolution Ah, the thrill of peering into the future of smart homes! That's what's cookin' as Parks Associates gears up for its annual CONNECTIONS™ Conference slated for May 4-6, 2027. This isn't just another routine pow-wow. Nope, this get-together is about seeing who's leading the pack in transforming our everyday spaces into...

Continue Reading
Brands Must Choose: Cost or Value Leadership?

Updated Category News Views 3

Navigating the Business Jungle: Strategic Choices Unveiled If you've ever found yourself tangled in a web of corporate doublespeak, then you'll nod along with this: all those lofty brand management strategies often boil down to a fight over dollars or dizzying customer satisfaction. What's the winning play? According to Info-Tech Research Group, it's about firmly standing...

Continue Reading
Starr Conspiracy Unveils AI Tool for B2B Tech Firms

Updated Category News Views 3

AI-Driven Insight in Minutes: A Game Changer for B2B Hold onto your hats, because The Starr Conspiracy just lit a fire in the B2B tech world with its latest offering—Battle Card Builder. This free tool cranks out competitive intelligence in no time, literally about four minutes. Geared specifically for B2B tech marketing and sales teams, it combines decades of know-how...

Continue Reading
Stravito's MCP Server Revolutionizes AI in Business

Updated Category News Views 6

We're seeing another big swing in how enterprises weave AI into the fabric of decision-making. Stravito, an enterprise customer intelligence platform, launched its Model Context Protocol (MCP) Server. This thing brings company-owned research right into the gizmos teams already use. Now, businesses aren't left groping in the dark figuring out their next moves—pretty...

Continue Reading
BeyondCPG Accelerator Launches Seventh Growth Program

Updated Category News Views 4

Fresh Faces in Conscious Consumerism There's nothing quite like an early morning jolt of caffeine mixed with the buzz of innovation in the air. BeyondCPG, a heavyweight in the conscious products arena, has cracked open the doors to its seventh round of powerhouse brand-boosting with the launch of its new Accelerator Track 7. They're mixing heart with hustle to give...

Continue Reading
VERTESS Tops Axial's 2026 Healthcare M&A Advisor List

Updated Category News Views 5

Strength Takes Top Spot in Healthcare M&A VERTESS has grabbed the gold medal in healthcare sell-side M&A, something that didn't just fall from the sky. Axial gave them the nod as the cream of the crop among the Top 50 Lower Middle Market Healthcare M&A Advisors for 2026. Evaluating the Strengths that Set VERTESS Apart When Axial, that private deal network that's all about...

Continue Reading
Lincoln Educational Services Faces Securities Fraud Suit

Updated Category News Views 2

A Storm Brews Over Lincoln Educational Services You know, there's nothing quite like the stink of a good mess in the markets, and Lincoln Educational Services Corporation has found itself knee-deep in one. The buzz is all about some securities fraud allegations that could rope in a bunch of investors who got the short end of the stick. It’s lawsuits like these that make...

Continue Reading
Clarius Named in TIME's Top HealthTech 2026 Again

Updated Category News Views 6

When a company gets the nod from TIME two years in a row, you know they’re not just tinkering with gadgets—they’re changing the game. Clarius Mobile Health, with its cutting-edge wireless ultrasound tech, has cemented its place in TIME's World's Top HealthTech Companies of 2026. Last I checked, repeating this kind of recognition never comes easy in such a fiercely...

Continue Reading
Alex Jones Returns to Austin: New Studio, New Plans

Updated Category News Views 5

Back in the Saddle: Austin's Controversy Stirs Again It looks like we're seeing a new chapter in a saga that just refuses to end. Alex Jones, the infamous firebrand who's plastered conspiracy theories across the airwaves for two decades, is returning to ground zero in Austin—the old InfoWars studio. After wading through bankruptcy muck and courtroom clashes, Jones is...

Continue Reading
Rise Treatment Center Launches in Vegas for Teens

Updated Category News Views 2

Las Vegas Debuts Rise Adolescent Treatment Center Imagine being a parent in Las Vegas, staring at the daunting task of finding genuine help for your teenage kid just entering those rebellious years. The choices usually feel sparse and lacking. But on August 13, 2026, a shimmer of hope illuminated the landscape with the opening of Rise Adolescent Treatment Center. It’s a...

Continue Reading

Top 5 Most Recently Viewed Articles

Phoenix Nest Lands Grant to Advance Gene Therapy

Updated Category News Views 19

Phoenix Nest's New Financial Boost and Its Mission Alright, folks, here’s the scoop. Phoenix Nest, a biotech company that’s as rare as the condition it’s fighting, has just bagged a $2.98 million Small Business Innovation Research (SBIR) grant. This isn’t just pocket change—it’s a lifeline for their mission to battle Sanfilippo Syndrome Type C with a...

Continue Reading
Peoples Bancorp Inc. Announces Attractive Quarterly Dividend

Updated Category News Views 133

Peoples Bancorp Inc. Announces Quarterly Dividend The Board of Directors of Peoples Bancorp Inc. (NASDAQ: PEBO) has officially declared a quarterly cash dividend of $0.41 per common share. This decision reflects the company’s strong financial performance and commitment to returning value to its shareholders. Details of the Dividend Declaration The dividend will be...

Continue Reading
Property Meld's New Acquisition: Transforming Maintenance with AI

Updated Category News Views 517

Property Meld Expands Capabilities with Mezo Acquisition Property Meld, recognized as a leader in the property maintenance operations sector, has made a significant advancement by acquiring Mezo, an innovative artificial intelligence software company. This strategic acquisition reflects Property Meld's ongoing commitment to improving property maintenance through enhanced...

Continue Reading
First Solar Faces Unique Challenges as BofA Adjusts Outlook

Updated Category News Views 75

First Solar's Adjusted Price Target by BofA Securities Recently, BofA Securities updated its perspective on First Solar (NASDAQ: FSLR), lowering the stock's price target from $321 to $269 while maintaining a Buy rating. This adjustment came in the wake of First Solar's report for the third quarter, reaffirming their positive outlook for the company despite the new...

Continue Reading
Exploring Surge in Movie Production Market Through 2028

Updated Category News Views 133

Growth in the Movie Production Market The global movie production market is on a promising trajectory, set to expand by USD 56.11 billion from 2024 to 2028. This growth rate corresponds to a compounded annual growth rate (CAGR) of 10.76%. As entertainment continues to evolve, this market reflects the dynamic changes in consumer preferences and technology. Market...

Continue Reading